A non-coding RNA lasso catches proteins in breast cancer cells

by Lisbeth Heilesen,Aarhus UniversityThe authors show that the long non-coding RNA called A-ROD (Activating Regulator Of DKK1 expression) is only functional the moment it is released from chroma

Updated on: May 20,2024

A non-coding RNA lasso catches proteins in breast cancer cells

by Lisbeth Heilesen,Aarhus UniversityThe authors show that the long non-coding RNA called A-ROD (Activating Regulator Of DKK1 expression) is only functional the moment it is released from chroma

Updated on:May 20,2024

Testosterone therapy may protect against breast cancer in trans masculine individuals

by Jacqueline Mitchell,Beth Israel Deaconess Medical Centera) Lobular atrophy was assessed by the pathologists using four categories. b) The duration of testosterone therapy (TT) significantly c

Updated on: August 03,2024

Testosterone therapy may protect against breast cancer in trans masculine individuals

by Jacqueline Mitchell,Beth Israel Deaconess Medical Centera) Lobular atrophy was assessed by the pathologists using four categories. b) The duration of testosterone therapy (TT) significantly c

Updated on:August 03,2024

Cancer survivors predicted to number over 22 million by 2030

by American Cancer SocietyCredit: CC0 Public DomainThere were more than 16.9 million Americans with a history of cancer on January 1, 2019, a number that is projected to reach more than 22.1 mill

Updated on: March 06,2024

Cancer survivors predicted to number over 22 million by 2030

by American Cancer SocietyCredit: CC0 Public DomainThere were more than 16.9 million Americans with a history of cancer on January 1, 2019, a number that is projected to reach more than 22.1 mill

Updated on:March 06,2024

Tissue stiffness is a "mosh pit" where cancer cells thrive

by Leslie Orr,University of Rochester Medical CenterCredit: CC0 Public DomainImagine being at a packed concert hall with a mosh pit full of dancers creating a wall against outsiders. When target

Updated on: March 24,2024

Tissue stiffness is a "mosh pit" where cancer cells thrive

by Leslie Orr,University of Rochester Medical CenterCredit: CC0 Public DomainImagine being at a packed concert hall with a mosh pit full of dancers creating a wall against outsiders. When target

Updated on:March 24,2024

Drug combination shows potential in aggressive leukemia

by Blake Belden,Virginia Commonwealth UniversityAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainAcute myeloid leukemia (AML) is an aggressive form of cancer that originates in

Updated on: December 28,2023

Drug combination shows potential in aggressive leukemia

by Blake Belden,Virginia Commonwealth UniversityAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainAcute myeloid leukemia (AML) is an aggressive form of cancer that originates in

Updated on:December 28,2023

New precision tools make quick work of tumor dissection

by Andrew Myers,Stanford UniversityScanning microscopy images of the microDicer (blade spacings 200 μm, 400 μm, and 800 μm, respectively) and microGrater. Credit: Seth Cordts and Saisneha Koppak

Updated on: September 30,2024

New precision tools make quick work of tumor dissection

by Andrew Myers,Stanford UniversityScanning microscopy images of the microDicer (blade spacings 200 μm, 400 μm, and 800 μm, respectively) and microGrater. Credit: Seth Cordts and Saisneha Koppak

Updated on:September 30,2024

Team develops effective cigar warning signage

byUniversity of North Carolina at Chapel Hill School of MedicineStimuli for the experimental conditions. Participants saw an image of a cigar store countertop at the point-of-sale with randomiza

Updated on: January 08,2024

Team develops effective cigar warning signage

byUniversity of North Carolina at Chapel Hill School of MedicineStimuli for the experimental conditions. Participants saw an image of a cigar store countertop at the point-of-sale with randomiza

Updated on:January 08,2024

Study weighs risks and benefits of phase I trials in pediatric cancer

by Public Library of ScienceSystematic review and meta-analysis finds 1 in 10 children who enroll in pediatric phase I cancer trials are improved after the trial, and 1 in 50 die from drug-relate

Updated on: June 28,2024

Study weighs risks and benefits of phase I trials in pediatric cancer

by Public Library of ScienceSystematic review and meta-analysis finds 1 in 10 children who enroll in pediatric phase I cancer trials are improved after the trial, and 1 in 50 die from drug-relate

Updated on:June 28,2024

Treatment of advanced non-small cell lung cancer with driver mutations

by Higher Education PressGraphical abstract. Credit:Frontiers of Medicine(2023). DOI: 10.1007/s11684-022-0976-4Lung cancer is the leading cause of cancer-related death worldwide. Improved

Updated on: March 30,2024

Treatment of advanced non-small cell lung cancer with driver mutations

by Higher Education PressGraphical abstract. Credit:Frontiers of Medicine(2023). DOI: 10.1007/s11684-022-0976-4Lung cancer is the leading cause of cancer-related death worldwide. Improved

Updated on:March 30,2024

Study offers new understanding of why kidney cancers become metastatic

by University of Texas M. D. Anderson Cancer CenterThis image shows a cross section of a kidney. Credit: Holly Fischer/WikipediaResearchers at The University of Texas MD Anderson Cancer have engi

Updated on: February 24,2024

Study offers new understanding of why kidney cancers become metastatic

by University of Texas M. D. Anderson Cancer CenterThis image shows a cross section of a kidney. Credit: Holly Fischer/WikipediaResearchers at The University of Texas MD Anderson Cancer have engi

Updated on:February 24,2024

Interdisciplinary research team uses AI to quickly discover personalized cancer cures

byLouisiana State UniversityCancerOmicsNet is a graph-based AI model. The LSU research team ran it on 2,300 drugs against 359 cancer cell lines—more than 800,000 combinations. CancerOmicsNet pre

Updated on: December 28,2023

Interdisciplinary research team uses AI to quickly discover personalized cancer cures

byLouisiana State UniversityCancerOmicsNet is a graph-based AI model. The LSU research team ran it on 2,300 drugs against 359 cancer cell lines—more than 800,000 combinations. CancerOmicsNet pre

Updated on:December 28,2023

Bioengineers combine lab-on-a-chip technology with AI to improve cancer immunotherapy

byIndiana UniversityTheplatform tracks T cell infiltration of tumor spheroids, which are 3D structures made of cancer cells. Credit: Feng GuoAn interdisciplinary team of researchers led by

Updated on: January 04,2024

Bioengineers combine lab-on-a-chip technology with AI to improve cancer immunotherapy

byIndiana UniversityTheplatform tracks T cell infiltration of tumor spheroids, which are 3D structures made of cancer cells. Credit: Feng GuoAn interdisciplinary team of researchers led by

Updated on:January 04,2024